Google
×
REVLIMID is indicated for the treatment of adult patients with mantle cell lymphoma. (MCL) whose disease has relapsed or progressed after two prior therapies, ...
People also ask
REVLIMID is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment ...
REVLIMID in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma (MM) who have received at least one prior therapy.
Revlimid® (lenalidomida) é indicado para o tratamento de pacientes com anemia dependente de transfusőes decorrente de síndrome mielodisplásica de risco baixo ou ...
Lenalidomide is used to treat various types of cancers. It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia.
Jan 31, 2024 · Lenalidomide is used to treat anemia (low red blood cells) in patients with a certain type of myelodysplastic syndrome (MDS).
Lenalidomide may lessen the need for blood transfusions.Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic ...
Revlimid in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy.
Apr 22, 2024 · Revlimid is a medication used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, and anemia in ...
The standard treatment dose for Revlimid is one 25 mg capsule each day for 21 days of a 28-day Cycle. Your physician may consider reducing the dose because of ...